Sector
Pharma VC Funds
Venture capital funds investing in pharmaceutical development, drug discovery, and clinical-stage biotech companies.
Zukunftsfonds Heilbronn, now rebranded as D11Z Ventures, is a prominent venture capital firm based in Heilbronn, Germany. The firm focuses on early-stage investments, particularly in digital business models across sectors like AI/Deep Tech, B2B SaaS, and asset-light IoT. D11Z Ventures, formerly known as Zukunftsfonds Heilbronn, has a clear mission to promote and support innovative digital ventures with both national and international impact, aiming to be the leading pre-seed and seed VC fund for AI in Europe. D11Z Ventures is known for its hands-on approach, providing startups not just with capital but also with strategic guidance, industry expertise, and access to a broad network of partners. The firm’s portfolio is diverse, with investments in startups that are shaping the future of various industries through technological innovation. Their rebranding to D11Z Ventures reflects a renewed commitment to innovation and sustainability in the rapidly evolving tech landscape. The firm is led by a team of experienced professionals who are deeply involved in the German and European startup ecosystems, actively supporting companies from the very early stages through to their growth and scaling phases.